JF
CALA

Jump Financial’s Calithera Biosciences, Inc CALA Stock Holding History

Jump Financial’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-940
Closed -$65K – 1253
2020
Q3 		$65K Buy
+940
New +$82K 0.01% 716

Other funds holding CALA

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
DMPV
Delphi Management Partners VIII San Mateo, California $138M AUM 56.74% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Jump Financial's CALA Position: Q4 2020 in Review

Jump Financial sold out of Calithera Biosciences, Inc (CALA) in Q4 2020, closing a stake of 940 shares — an estimated $65K sold.

Jump Financial first reported a position in CALA in Q3 2020 and held it in 1 quarter. The position peaked at $65K in Q3 2020. 105 funds tracked by Wall St. Rank hold CALA as of Q4 2020.

  • Jump Financial reported no remaining Calithera Biosciences, Inc position as of Q4 2020 after selling out during the quarter.
  • Jump Financial sold 940 Calithera Biosciences, Inc shares in Q4 2020, an estimated $65K.
  • Jump Financial first reported a position in Calithera Biosciences, Inc in Q3 2020 and held it in 1 quarter.
  • Jump Financial's Calithera Biosciences, Inc position peaked at $65K in Q3 2020.
  • 105 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q4 2020.

Based on Jump Financial's 13F filing for Q4 2020, filed 12 Feb 2021.